BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 14962746)

  • 21. Alpha-synuclein and its neurotoxic fragment inhibit dopamine uptake into rat striatal synaptosomes. Relationship to nitric oxide.
    Adamczyk A; Kaźmierczak A; Strosznajder JB
    Neurochem Int; 2006 Sep; 49(4):407-12. PubMed ID: 16546300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress.
    Sawada H; Ibi M; Kihara T; Urushitani M; Akaike A; Kimura J; Shimohama S
    Ann Neurol; 1998 Jul; 44(1):110-9. PubMed ID: 9667598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential involvement of cyclase- versus non-cyclase-coupled D1-like dopamine receptors in orofacial movement topography in mice: studies with SKF 83822.
    Makihara Y; Okuda Y; Kawada C; Matsumoto M; Waddington JL; Koshikawa N; Tomiyama K
    Neurosci Lett; 2007 Mar; 415(1):6-10. PubMed ID: 17234342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium modulates dopamine potentiation of N-methyl-D-aspartate responses: electrophysiological and imaging evidence.
    Liu JC; DeFazio RA; Espinosa-Jeffrey A; Cepeda C; de Vellis J; Levine MS
    J Neurosci Res; 2004 May; 76(3):315-22. PubMed ID: 15079860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine promotes striatal neuronal apoptotic death via ERK signaling cascades.
    Chen J; Rusnak M; Lombroso PJ; Sidhu A
    Eur J Neurosci; 2009 Jan; 29(2):287-306. PubMed ID: 19200235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine-glutamate interaction in rat striatal slices: changes of CCDPK II, PKA, and LDH activity by receptor-mediated mechanisms.
    Tang FM; Sun YF; Wang R; Ding YM; Zhang GY; Jin GZ
    Acta Pharmacol Sin; 2000 Feb; 21(2):145-50. PubMed ID: 11263261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of dopamine uptake by nitric oxide in cultured mesencephalic neurons.
    Salum C; Raisman-Vozari R; Michel PP; Gomes MZ; Mitkovski M; Ferrario JE; Ginestet L; Del Bel EA
    Brain Res; 2008 Mar; 1198():27-33. PubMed ID: 18255050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD; Pierce RC
    Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurochemical and behavioral responses to cocaine in adult male rats with neonatal isolation experience.
    Kosten TA; Zhang XY; Kehoe P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):661-7. PubMed ID: 15845857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prefrontal cortex and basolateral amygdala modulation of dopamine-mediated locomotion in the nucleus accumbens core.
    Rouillon C; Abraini JH; David HN
    Exp Neurol; 2008 Jul; 212(1):213-7. PubMed ID: 18501353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic treatment with (-)-stepholidine alters density and turnover of D1 and D2 receptors in striatum.
    Zou LL; Cai ST; Jin GZ
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):485-9. PubMed ID: 9863137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function.
    Heidenreich BA; Mitrovic I; Battaglia G; Napier TC
    Exp Neurol; 2004 Apr; 186(2):145-57. PubMed ID: 15026253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopaminergic regulation of orexin neurons.
    Bubser M; Fadel JR; Jackson LL; Meador-Woodruff JH; Jing D; Deutch AY
    Eur J Neurosci; 2005 Jun; 21(11):2993-3001. PubMed ID: 15978010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of dopamine-glutamate interactions on striatal neuronal nitric oxide synthase activity.
    Hoque KE; Indorkar RP; Sammut S; West AR
    Psychopharmacology (Berl); 2010 Jan; 207(4):571-81. PubMed ID: 19816675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions.
    Jutkiewicz EM; Bergman J
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1008-15. PubMed ID: 15292458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subthalamic nucleus lesions alter basal and dopamine agonist stimulated electrophysiological output from the rat basal ganglia.
    Zahr NM; Martin LP; Waszczak BL
    Synapse; 2004 Nov; 54(2):119-28. PubMed ID: 15352137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine(D1) and serotonin(2) receptors and is targeted to tachykinin neurons of the dorsomedial striatum.
    Campbell BM; Gresch PJ; Walker PD
    Neuroscience; 2001; 105(3):671-80. PubMed ID: 11516832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine (D1) receptor activation and nitrinergic agents influence somatostatin levels in rat retina.
    Kiagiadaki F; Koulakis E; Thermos K
    Exp Eye Res; 2008 Jan; 86(1):18-24. PubMed ID: 17961553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
    Campbell BM; Kreipke CW; Walker PD
    Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.